Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2021 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
BacMam virus-based surface display for HCV E2 glycoprotein induces strong cross-neutralizing antibodies and cellular immune responses in vaccinated mice.
Infect Agent Cancer. 2021 Dec 18;16(1):69. doi: 10.1186/s13027-021-00407-x.
Infect Agent Cancer. 2021.
PMID: 34922563
Free PMC article.
HCV Core/NS3 Protein Immunization with "N-Terminal Heat Shock gp96 Protein (rNT (gp96))" Induced Strong and Sustained Th1-Type Cytokines in Immunized Mice.
Hajikhezri Z, Roohvand F, Maleki M, Shahmahmoodi S, Amirzargar AA, Keshavarz A, Seyed N, Farahmand M, Samimi-Rad K.
Hajikhezri Z, et al. Among authors: keshavarz a.
Vaccines (Basel). 2021 Mar 3;9(3):215. doi: 10.3390/vaccines9030215.
Vaccines (Basel). 2021.
PMID: 33802466
Free PMC article.
Item in Clipboard
A non-pathogenic Leishmania tarentolae vector based- HCV polytope DNA vaccine elicits potent and long lasting Th1 and CTL responses in BALB/c mice model.
Ansari N, Rafati S, Taheri T, Roohvand F, Farahmand M, Hajikhezri Z, Keshavarz A, Samimi-Rad K.
Ansari N, et al. Among authors: keshavarz a.
Mol Immunol. 2019 Jul;111:152-161. doi: 10.1016/j.molimm.2019.04.009. Epub 2019 May 1.
Mol Immunol. 2019.
PMID: 31054409
Item in Clipboard
Cite
Cite